(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration has extended the review period for Blenrep combinations in relapsed/refractory multiple myeloma after an advisory ...

GoodRx will pay $25 million to settle claims it shared users’ sensitive data with third parties like Meta and Google without ...

Antimicrobial resistance (AMR) is a critical global health threat, with ESKAPE pathogens — Enterococcus faecium, ...

Over the past three decades, tremendous achievements have been made in the treatment of patients with multiple myeloma (MM), ...